Edition:
India

Cleveland Biolabs Inc (CBLI.OQ)

CBLI.OQ on NASDAQ Stock Exchange Capital Market

3.87USD
19 Jan 2018
Change (% chg)

-- (--)
Prev Close
$3.87
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,078
52-wk High
$5.55
52-wk Low
$1.41

Chart for

About

Cleveland BioLabs, Inc. (CBLI) is a biopharmaceutical company. The Company is engaged in developing approaches to activate the immune system and address serious medical needs. Its platform of Toll-like immune receptor activators has applications in mitigation of radiation injury and immuno-oncology. Its advanced product... (more)
No analyst recommendations are available for .

Overall

Beta: -0.19
Market Cap(Mil.): $39.37
Shares Outstanding(Mil.): 11.28
Dividend: --
Yield (%): --

Financials

BRIEF-Cleveland BioLabs reports Q3 ‍net loss per share, excluding minority interests, $0.11

* Cleveland BioLabs reports third quarter 2017 financial results and development progress

14 Nov 2017

BRIEF-Cleveland BioLabs Q2 loss per share $0.50‍​

* Cleveland BioLabs reports second quarter 2017 financial results and development progress

14 Aug 2017

Earnings vs. Estimates